The Multidisciplinary Treatment Planning Conference (Brain Tumor Board) is a venue for specialty experts to review and discuss the medical condition and treatment options of a patient. Also called a multidisciplinary opinion, the Neuro-oncology Brain Tumor Board at the TNOL is attended by Neuro-oncologists (A physician with special training for the diagnosis and medical treatment of tumors of the nervous system), Neuro-Surgeons (A surgeon who specializes in the diagnosis, treatment, and surgical management of disorders and disease of the brain, spine, and nervous system), Neuropathologists (Physicians who examine biopsy tissue from the brain and spinal cord to aid in diagnosis of disease), Neuro-imaging specialists or Neuroradiologists (Radiologist who specializes on the diagnosis and characterization of abnormalities of the central and peripheral nervous system, spine, and head and neck), and Radiation Oncologists (Physicians who specializes in the treatment of cancer patients, using radiation therapy as the main modality of treatment).
The Brain Tumor Board is held every Wednesday 10:00 AM. Non JWCI cases can be presented and must be arranged with Dr. Santosh Kesari at KesariS@jwci.org or Marlon Saria at SariaM@jwci.org. To allow for advanced case review by the different specialties, we are requesting that cases be submitted by Tuesday at 12:00 noon to be included in the case list that will be presented that week.
MULTIDISCIPLINARY TREATMENT PLANNING CONFERENCE (BRAIN TUMOR BOARD)
The Neuro-oncology Conference at TNOL, brings together scientists and clinicians to bridge discoveries about brain tumors from the laboratory to clinical practice. This conference gathers within the same scientific forum all specialties involved in the early diagnosis and treatment of the neoplastic diseases of the nervous system in order to exchange experience and ideas and to offer a model of an interdisciplinary collaboration.
The conference is held every Wednesday at 7:30 AM.
If you want to receive weekly notifications of the conference topics and speakers, please send your subscription request to Marlon Saria at SariaM@jwci.org.
NEURO-ONCOLOGY CONFERENCE AT TNOL
The Neuro-Oncology Fellowship is a training program in development therapeutics focused on cancer drugs. Our vision is that cancer can be controlled with novel therapeutics directed at molecular targets critical for tumor cell survival when combined with biomarkers that allow individualization of treatment. The mission of the program is to provide training to post-doctoral PhD scientists and physicians in each of the major steps in the development of a novel cancer therapeutic so as to position these individuals to play leading roles in translating laboratory-based discoveries into safe and effective therapeutic agents.
The training program will have two components: 1) the completion of formal didactic courses on the drug development.process; and, 2) the conduct of a drug development research project under the direction of a faculty mentor. The trainees will also be required to attend Cancer Center and other institutional seminars, workshops and journal clubs and attend the annual American Association for Cancer Research meeting.
Neuro-Oncology FELLOWSHIP SEMINAR SERIES
NEURO-ONCOLOGY EDUCATION & TRAINING PROGRAM
TRANSLATIONAL NEURO-ONCOLOGY LABORATORIES (TNOL)
SANTOSH KESARI, MD, PhD